These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 25253504)

  • 1. Adjusting for comorbidities in cost of illness studies.
    Rizzo JA; Chen J; Gunnarsson CL; Naim A; Lofland JH
    J Med Econ; 2015 Jan; 18(1):12-28. PubMed ID: 25253504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medical care expenditures for diabetes, its chronic complications, and its comorbidities.
    Hodgson TA; Cohen AJ
    Prev Med; 1999 Sep; 29(3):173-86. PubMed ID: 10479605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Economic costs of diabetes in the U.S. In 2007.
    American Diabetes Association
    Diabetes Care; 2008 Mar; 31(3):596-615. PubMed ID: 18308683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comorbidity Status and Annual Total Medical Expenditures in U.S. Hypertensive Adults.
    Park C; Fang J; Hawkins NA; Wang G
    Am J Prev Med; 2017 Dec; 53(6S2):S172-S181. PubMed ID: 29153118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Economic burden of patients with anemia in selected diseases.
    Ershler WB; Chen K; Reyes EB; Dubois R
    Value Health; 2005; 8(6):629-38. PubMed ID: 16283863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Direct medical costs and their predictors in patients with rheumatoid arthritis: a three-year study of 7,527 patients.
    Michaud K; Messer J; Choi HK; Wolfe F
    Arthritis Rheum; 2003 Oct; 48(10):2750-62. PubMed ID: 14558079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The cost of obesity in Canada.
    Birmingham CL; Muller JL; Palepu A; Spinelli JJ; Anis AH
    CMAJ; 1999 Feb; 160(4):483-8. PubMed ID: 10081464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of diabetes mellitus on healthcare costs in Italy.
    Giorda CB; Manicardi V; Diago Cabezudo J
    Expert Rev Pharmacoecon Outcomes Res; 2011 Dec; 11(6):709-19. PubMed ID: 22098288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The economic burden of diabetes.
    Dall TM; Zhang Y; Chen YJ; Quick WW; Yang WG; Fogli J
    Health Aff (Millwood); 2010 Feb; 29(2):297-303. PubMed ID: 20075080
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of comorbidities and their associations with health-related quality of life and healthcare expenditures in patients with rheumatoid arthritis.
    An J; Nyarko E; Hamad MA
    Clin Rheumatol; 2019 Oct; 38(10):2717-2726. PubMed ID: 31134504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methodological challenges in assessing the impact of comorbidities on costs in Alzheimer's disease clinical trials.
    Kahle-Wrobleski K; Fillit H; Kurlander J; Reed C; Belger M
    Eur J Health Econ; 2015 Dec; 16(9):995-1004. PubMed ID: 25410743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Juvenile obesity and comorbidity type 2 diabetes mellitus (T2 DM) in Germany: development and cost-of-illness analysis].
    Wolfenstetter SB
    Gesundheitswesen; 2006 Oct; 68(10):600-12. PubMed ID: 17099820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incremental treatment expenditure of diabetes in the United States.
    Balu S
    Manag Care Interface; 2007 Apr; 20(4):20-7. PubMed ID: 17474327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost of diabetes: comparison of disease-attributable and matched cohort cost estimation methods.
    Tunceli O; Wade R; Gu T; Bouchard JR; Aagren M; Luo W
    Curr Med Res Opin; 2010 Aug; 26(8):1827-34. PubMed ID: 20491613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost of illness and quality of life of patients with rheumatoid arthritis in South Korea.
    Lee TJ; Park BH; Son HK; Song R; Shin KC; Lee EB; Song YW
    Value Health; 2012; 15(1 Suppl):S43-9. PubMed ID: 22265066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between different types of comorbidity and disease burden in patients with diabetes.
    An J; Le QA; Dang T
    J Diabetes; 2019 Jan; 11(1):65-74. PubMed ID: 29956479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-of-illness studies : a review of current methods.
    Akobundu E; Ju J; Blatt L; Mullins CD
    Pharmacoeconomics; 2006; 24(9):869-90. PubMed ID: 16942122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-offsets of prescription drug expenditures: data analysis via a copula-based bivariate dynamic hurdle model.
    Deb P; Trivedi PK; Zimmer DM
    Health Econ; 2014 Oct; 23(10):1242-59. PubMed ID: 23956147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trends in health care expenditure in U.S. adults with diabetes: 2002-2011.
    Ozieh MN; Bishu KG; Dismuke CE; Egede LE
    Diabetes Care; 2015 Oct; 38(10):1844-51. PubMed ID: 26203060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Detailed analysis of the societal costs of diabetes mellitus].
    van Os N; Niessen LW; Koopmanschap MA; van der Lei J
    Ned Tijdschr Geneeskd; 2000 Apr; 144(18):842-6. PubMed ID: 10816774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.